Miral, Eny P.

HRN: 27-79-95  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/12/2025
CEFTRIAXONE 1G (VIAL)
09/12/2025
09/19/2025
IV
2g
OD
Nonhealing Wound
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines